Paul Mitchell

The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment

D. Cameron, J. Thomson, P. Hall, 2023, The oncologist.